More on INHX
Data
Financials
News
Click line-items for a historical chart and %
| License fees and milestones | 1.01M |
| Collaborative research and development | 250K |
| Total revenue | 1.26M |
| Research and development | 5.68M |
| General and administrative | 888.89K |
| Total operating expense | 6.56M |
| Loss from operations | -5.3M |
| Other income (loss), net | -7.12K |
| Interest income, net | 32.43K |
| Net loss | -5.28M |
| Basic and diluted net loss per share | -0.07 |
| Weighted average shares used to compute basic and diluted net loss per share | 78.12M |
Entities mentioned with INHX
- Earnings | View Related Stories »
- Bristol-Myers Squibb/Inhibitex | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Gilead Sciences/Pharmasset | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Dividend | View Related Stories »
- Bankruptcy | View Related Stories »
- Deutsche Bank | View Related Stories »
- Show More...
